[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335521-105":59,"doc-detail-335521-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-multi-omics-analysis-identifies-chromatin-regulator-related-signatures-and-tff1-as-a-therapeutic-target-in-lung-adenocarcinoma-research-summary","Comprehensive multi-omics analysis identifies chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma - Research summary","","Comprehensive multi-omics analysis establishes a chromatin regulator-related signature (CRRS) to predict survival in lung adenocarcinoma (LUAD) using a 429-combination machine learning strategy. The CRRS is validated across independent datasets and linked to immune microenvironment features through immune cell infiltration changes. High-risk LUAD shows enriched cell-cycle and DNA-repair activity, distinct mutation profiles, and differential immune responses. The study further identifies TFF1 as a therapeutic target, showing that TFF1 knockdown suppresses LUAD proliferation, promotes apoptosis, and reduces in vivo tumor growth, supported by Ki67 and TUNEL assays.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-multi-omics-analysis-identifies-chromatin-regulator-related-signatures-and-tff1-as-a-therapeutic-target-in-lung-adenocarcinoma-research-summary/335521/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-multi-omics-analysis-identifies-chromatin-regulator-related-signatures-and-tff1-as-a-therapeutic-target-in-lung-adenocarcinoma-research-summary/335521.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the CRRS model predict in LUAD patients?","Question",{"text":112,"@type":113},"The CRRS model predicts survival outcomes in lung adenocarcinoma patients and stratifies them into different risk groups.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is the tumor immune microenvironment related to CRRS?",{"text":117,"@type":113},"CRRS modulates immune cell infiltration in the tumor microenvironment, with high-risk and low-risk groups showing distinct immune responses.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is TFF1 considered a therapeutic target in this study?",{"text":121,"@type":113},"TFF1 knockdown significantly inhibits LUAD cell proliferation, induces apoptosis, suppresses in vivo tumor growth, and is supported by Ki67 and TUNEL assays.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335521,1790381002,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 30 October 2024  \nDOI 10.3389/fimmu.2024.1481753  \nOPEN ACCESS  \nEDITED BY  \nWantao Wu,  \nChongqing Medical University, China  \nREVIEWED BY  \nZhijie Zhao,  \nShanghai Jiao Tong University, China Renjun Gu,  \nNanjing University of Chinese Medicine, China  \n*CORRESPONDENCE  \nWen Shen  \n [shenwen0212@qq.com](shenwen0212@qq.com)[ ](shenwen0212@qq.com)Xiaye Miao  \n [miaoxiaye@163.com](miaoxiaye@163.com)[ ](miaoxiaye@163.com)Xiaoqing Liang  \n [lxq19980314@163.com](lxq19980314@163.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 16 August 2024  \nACCEPTED 07 October 2024  \nPUBLISHED 30 October 2024  \nCITATION  \nFan J, Chen BG, Wu H, Liang X, Shen W and Miao X (2024) Comprehensive multi-omics analysis identiﬁes chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma through a 429-  \ncombination machine learning approach. Front. Immunol. 15:1481753 .  \ndoi: 10.3389/fimmu.2024.1481753  \nCOPYRIGHT  \n© 2024 Fan, Chen, Wu, Liang, Shen and Miao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nComprehensive multi-omics analysis identiﬁes chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma through a 429-combination machine learning approach  \nJun Fan 1†, BoGuang Chen 2†, Hao Wu 3†, Xiaoqing Liang 4*, Wen Shen 5* and Xiaye Miao 6*  \n1 Department of Thoracic Surgery, The First Afﬁliated Hospital of Nanjing Medical University, Nanjing, China, 2Oncology Department I, Huai’an 82 Hospital, Huai’an, Jiangsu, China, 3 Department of Oncology, The Afﬁliated Huai’an Hospital of Xuzhou Medical University and The Second People’s Hospital of Huai’an, Huai’an, Jiangsu, China, 4 Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China, 5 Department of Respiratory Diseases, The Afﬁliated Huai’an Hospital of Xuzhou Medical University, The Second People’s Hospital of Huai’an, Huai’an,  \nJiangsu, China, 6 Department of Laboratory Medicine, Northern Jiangsu People’s Hospital, Yangzhou, China  \nIntroduction: Lung cancer is a leading cause of cancer-related deaths, with its incidence continuing to rise. Chromatin remodeling, a crucial process in gene expression regulation, plays a signiﬁcant role in the development and progression of malignant tumors. However, the role of chromatin regulators (CRs) in lung adenocarcinoma (LUAD) remains underexplored.  \nMethods: This study developed a chromatin regulator-related signature (CRRS) using a 429-combination machine learning approach to predict survival outcomes in LUAD patients. The CRRS model was validated across multiple independent datasets. We also investigated the impact of CRRS on the immune microenvironment, focusing on immune cell inﬁltration. To identify potential therapeutic targets, TFF1, a chromatin regulator, was knocked down using siRNAin LUAD cells. We assessed its impact through apoptosis analysis, proliferation assays, and in vivo tumor growth studies. Additional validation was performed using Ki67 expression and TUNEL assays.  \nResults: The CRRS accurately predicted survival outcomes and was shown to modulate immune cell inﬁltration in the tumor microenvironment. High-risk patients demonstrated increased activity in cell cycle regulation and DNA repair pathways, along with distinct mutation proﬁles and immune responses compared to low-risk patients. TFF1 emerged as a key therapeutic target. Knockdown of TFF1 signiﬁcantly inhibited LUAD cell proliferation, induced apoptosis, and suppressed in vivo tumor growth. Ki","cbCaijjrxhc8wz3Q","https://ap.wps.com/l/cbCaijjrxhc8wz3Q","pdf",9950753,18,"English","# Introduction\n# Methods\n# Results\n# Discussion","[{\"question\":\"What does the CRRS model predict in LUAD patients?\",\"answer\":\"The CRRS model predicts survival outcomes in lung adenocarcinoma patients and stratifies them into different risk groups.\"},{\"question\":\"How is the tumor immune microenvironment related to CRRS?\",\"answer\":\"CRRS modulates immune cell infiltration in the tumor microenvironment, with high-risk and low-risk groups showing distinct immune responses.\"},{\"question\":\"Why is TFF1 considered a therapeutic target in this study?\",\"answer\":\"TFF1 knockdown significantly inhibits LUAD cell proliferation, induces apoptosis, suppresses in vivo tumor growth, and is supported by Ki67 and TUNEL assays.\"}]","Comprehensive multi-omics analysis identifies chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma - Research summary | PDF",1790011283,45]